Phase II trial of twice daily oral topotecan in combination with hyperfractionated radiotherapy for limited stage small cell lung carcinoma

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 7522-7522
Author(s):  
C. W. Hodge ◽  
P. Legenne ◽  
P. Wissel ◽  
J. H. Schiller ◽  
M. P. Mehta
Keyword(s):  
Phase Ii ◽  
Lung Carcinoma ◽  
Phase Ii Trial ◽  
Small Cell Lung Carcinoma ◽  
Small Cell ◽  
Small Cell Lung ◽  
Cell Lung Carcinoma ◽  
Hyperfractionated Radiotherapy ◽  
Limited Stage ◽  
Oral Topotecan

scholarly journals Phase II trial of a non‐platinum triplet for patients with advanced non‐small cell lung carcinoma (NSCLC) overexpressing ERCC1 messenger RNA

2019 ◽  
Vol 10 (3) ◽  
pp. 452-458 ◽  
Author(s):  
Shinnosuke Takemoto ◽  
Yoichi Nakamura ◽  
Hiroshi Gyoutoku ◽  
Hiroaki Senju ◽  
Daiki Ogawara ◽  
...  
Keyword(s):  
Phase Ii ◽  
Lung Carcinoma ◽  
Messenger Rna ◽  
Phase Ii Trial ◽  
Small Cell Lung Carcinoma ◽  
Small Cell ◽  
Small Cell Lung ◽  
Cell Lung Carcinoma
Sign in / Sign up

Export Citation Format

Share Document